Atlas Venture News
Most Popular Atlas Venture Story
Bluebird's gene therapy song attracts $30M venture round
Arch Venture Partners has joined a group of top venture players to help back Cambridge, MA-based bluebird bio with a $30 million venture commitment, capping a $35 million round completed a little Read more...
Latest Headlines
- December 15, 2011
- April 20, 2011
- May 19, 2008
- September 10, 2007
- January 10, 2007
- July 12, 2006
- March 22, 2006
- March 8, 2006
- March 2, 2006
- January 8, 2006
- August 10, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
